We noted you are experiencing viewing problems
- 
        
        Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
 - 
        
        Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. - 
        
        No luck yet? More tips for troubleshooting viewing issues
 - 
        
        Contact HST Support access@hstalks.com
 
- 
        Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
 - 
        For additional help, please don't hesitate to contact HST support access@hstalks.com
 
We hope you have enjoyed this limited-length demo
                    
                    This is a limited length demo talk; you may
                    
                      login or
                    
                    review methods of
                    obtaining more access.
                  
                
                
              Printable Handouts
Navigable Slide Index
- Introduction
 - p53 is a tumor suppressor
 - Evidence that p53 is a tumor suppressor
 - Additional evidence that p53 is a tumor suppressor
 - Half of all human cancers carry p53 mutations
 - p53 is a sequence-specific transcription factor
 - Schematic structure of p53 protein
 - Example: the biological activities of p53
 - Effect of temperature-sensitive p53 activation
 - Induction of cell death by activated p53
 - Activated p53 induces apoptosis in leukemic cells
 - p53 is activated by oncogenic stress
 - p53 is activated by various cellular stress types
 - Induction of p53 by DNA damage (cisplatin)
 - How is p53 activated?
 - Some p53 target genes
 - Activity of transcriptional activation-deficient p53
 - Translocation of p53 in response to DNA damage
 - Transcription activity in response to DNA damage
 - Mitochondrially targeted p53
 - Mitochondrially targeted p53 induces apoptosis
 - Transcriptional activation-deficient and wt p53
 - PUMA releases p53 from Bcl-xL
 - Integrated apoptotic activities of p53
 - How is p53 activity restrained in absence of stress
 - MDM2 - a negative regulator of p53
 - Basic facts about MDM2
 - How does MDM2 inactivate p53?
 - MDM2 promotes degradation of p53
 - p53 levels determine its fate
 - p53-MDM2 negative autoregulatory feedback loop
 - Disrupting the p53-MDM2 feedback loop
 - p53 in evolution
 - p53 transcriptional activity in drosophila embryo
 - Effect of dominant negative p53 activity in the fly
 - C.elegans p53 is required for germ cell apoptosis
 - How is the outcome of p53 activation determined
 - p53 activation: growth arrest or cell death?
 - Induction of p21 by p53 can inhibit apoptosis
 - Some p53 target genes are anti-apoptotic
 - p53 mutations lead to different effects on its action
 - Mutant p53 overexpression prevents apoptosis
 - Mutant p53 protects cancer cells from killing
 - Knock-down of mutant p53 restores killing
 - Mutant p53 down-regulates surface CD95 protein
 - Mutant p53 down-regulates the CD95 promoter
 - p53-based cancer therapy
 - p53-MDM2 binding
 - Drugs that disrupt p53-mdm2 binding - Nutlin
 - Nutlin induces p53 activation/ tumor regression
 - PRIMA-1 affects mutant p53
 - PRIMA-1 synergizes with cisplatin
 - Summary
 
Topics Covered
- p53 as a tumor suppressor
 - Regulation of transcription by p53
 - Activation of p53 by oncogenic stress
 - Transcriptional and non-transcriptional mechanisms for p53- mediated apoptosis
 - Regulation of p53 by Mdm2
 - Evolutionary conservation of p53 function
 - Mutant p53 gain of function
 - p53-based cancer therapy
 
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Oren, M. (2007, October 1). p53 and apoptosis [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 4, 2025, from https://doi.org/10.69645/AYTF7064.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Moshe Oren has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.